(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.

Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

The LDH revealed that the patient was over age 65, had underlying medical conditions and contracted bird flu after exposure ...

RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...

GSK PLC GSK shares inched up 0.71% to £13.50 Monday, on what proved to be an all-around positive trading session for the ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

DIA, a global non-profit organization of life sciences professionals, will examine the integration of artificial intelligence (AI) in safety workflows and the impact of real-world evidence (RWE) ...

Boltwood Capital Management lifted its stake in GSK plc (NYSE:GSK – Free Report) by 9.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund ...

Insider Monkey’s third quarter database indicates that 38 hedge funds were bullish on GSK plc (NYSE:GSK), compared to 36 ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

Drugmaker GSK said, a stamp has been released by India Post to commemorate its 100 years in India. The ₹5 denomination stamp ...